XML 35 R6.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Preferred Stock
Common Stock
Additional Paid-in Capital
Retained Earnings
AOCI Attributable to Parent
Accounting Standards Update 2016-13
Accounting Standards Update 2016-13
Retained Earnings
Balance (in shares) at Dec. 31, 2020     75,850,000          
Balance at Dec. 31, 2020 $ 4,904,611 $ 217,126 $ 75,850 $ 3,028,063 $ 1,407,723 $ 175,849    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Exercise of employee common stock options, stock appreciation rights, and related tax benefits (in shares) 45,125   45,000          
Exercise of employee common stock options, stock appreciation rights, and related tax benefits $ 1,001   $ 45 956        
Dividends, Preferred Stock, Cash 15,192       (15,192)      
Common dividends paid 55,504       (55,504)      
Issuance of restricted common shares, net of forfeitures (in shares)     213,000          
Issuance of restricted common shares, net of forfeitures 0   $ 213 (213)        
Restricted shares withheld for taxes & related tax benefit     88,000          
Issuance of restricted common shares, net of forfeitures (3,790)   $ 88 (3,878)        
Restricted shares withheld for taxes (in shares)     (53,000)          
Issuance of restricted common shares, net of forfeitures (4,131)   $ (53) (4,078)        
Stock-based compensation expense 24,952     24,952        
Net income 527,323       527,323      
Other Comprehensive Income (Loss) (68,663)         (68,663)    
Balance (in shares) at Dec. 31, 2021     76,143,000          
Balance at Dec. 31, 2021 $ 5,310,607 217,126 $ 76,143 3,045,802 1,864,350 107,186    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Exercise of employee common stock options, stock appreciation rights, and related tax benefits (in shares) 15,959   16,000          
Exercise of employee common stock options, stock appreciation rights, and related tax benefits $ 328   $ 16 312        
Dividends, Preferred Stock, Cash 15,192       (15,192)      
Common dividends paid 68,194       (68,194)      
Issuance of restricted common shares, net of forfeitures (in shares)     250,000          
Issuance of restricted common shares, net of forfeitures 0   $ 250 (250)        
Restricted shares withheld for taxes & related tax benefit     96,000          
Issuance of restricted common shares, net of forfeitures (5,462)   $ 96 (5,558)        
Restricted shares withheld for taxes (in shares)     (51,000)          
Issuance of restricted common shares, net of forfeitures (5,042)   $ (51) (4,991)        
Stock-based compensation expense 39,552     39,552        
Net income 560,742       560,742      
Other Comprehensive Income (Loss) (297,947)         (297,947)    
Balance (in shares) at Dec. 31, 2022     76,454,000          
Balance at Dec. 31, 2022 $ 5,519,392 217,126 $ 76,454 3,074,867 2,341,706 (190,761)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Exercise of employee common stock options, stock appreciation rights, and related tax benefits (in shares) 40,188   40,000          
Exercise of employee common stock options, stock appreciation rights, and related tax benefits $ 971   $ 40 931        
Dividends, Preferred Stock, Cash 15,192       (15,192)      
Common dividends paid 68,737       (68,737)      
Issuance of restricted common shares, net of forfeitures (in shares)     235,000          
Issuance of restricted common shares, net of forfeitures 0   $ 235 (235)        
Restricted shares withheld for taxes & related tax benefit     97,000          
Issuance of restricted common shares, net of forfeitures (3,725)   $ 97 (3,822)        
Restricted shares withheld for taxes (in shares)     (59,000)          
Issuance of restricted common shares, net of forfeitures (4,186)   $ (59) (4,127)        
Stock-based compensation expense 41,879     41,879        
Net income 562,152       562,152      
Cumulative effect of change in accounting principle [1]             $ (35,002) $ (35,002)
Other Comprehensive Income (Loss) 38,236         38,236    
Balance (in shares) at Dec. 31, 2023     76,767,000          
Balance at Dec. 31, 2023 $ 6,035,788 $ 217,126 $ 76,767 $ 3,109,493 $ 2,784,927 $ (152,525)    
[1] Represents the impact of Banker's Healthcare Group's adoption of ASU 2016-13. See Note 2. Equity Method Investment.